CTI BioPharma Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	24	23	29	38	27
Market Cap Growth	-21.81%	-21.81%	-22.91%	41.55%	-
Enterprise Value	25	24	27	37	-
Last Close Price	0.48	0.47	0.73	1.06	0.83
PB Ratio	9.98	9.40	9.57	9.26	6.48
P/TBV Ratio	-	-	-	9.05	6.49
P/FCF Ratio	-	-	-	-	1521.91
P/OCF Ratio	-	-	-	-	1521.91
Debt / Equity Ratio	0.27	0.27	0.22	0.00	0.26
Debt / FCF Ratio	-	-	-	-	60.79
Quick Ratio	0.09	0.09	0.31	2.26	0.74
Current Ratio	0.21	0.21	0.66	3.44	3.15
Return on Equity (ROE)	-202.75%	-202.75%	-155.28%	-105.55%	-
Return on Assets (ROA)	-54.77%	-54.77%	-60.26%	-47.04%	-
Return on Capital (ROIC)	-99.96%	-99.96%	-87.72%	-57.95%	-
Earnings Yield	-23.73%	-25.22%	-18.20%	-11.91%	-6.14%
FCF Yield	-12.72%	-13.51%	-22.79%	-13.37%	0.07%
Buyback Yield / Dilution	-16.46%	-16.46%	-18.64%	-30.31%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.